Dr. Leland Gershell

Oppenheimer & Co.

Recent Articles about Capricor Therapeutics Inc.

Biotech Discovers Breakthrough DMD Therapy Opportunity 09/26/2025

Capricor Therapeutics Inc. (CAPR:NASDAQ) recently announced a favorable regulatory update, according to a research note from Oppenheimer & Co Inc.